Suheung Co., Ltd. (KRX:008490)
19,210
+740 (4.01%)
At close: Jun 2, 2025, 3:30 PM KST
Suheung Revenue
Suheung had revenue of 180.84B KRW in the quarter ending March 31, 2025, with 9.38% growth. This brings the company's revenue in the last twelve months to 668.77B, up 10.61% year-over-year. In the year 2024, Suheung had annual revenue of 653.26B with 9.87% growth.
Revenue (ttm)
668.77B
Revenue Growth
+10.61%
P/S Ratio
0.32
Revenue / Employee
908.65M
Employees
736
Market Cap
213.60B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 653.26B | 58.70B | 9.87% |
Dec 31, 2023 | 594.57B | -40.40B | -6.36% |
Dec 31, 2022 | 634.97B | 38.23B | 6.41% |
Dec 31, 2021 | 596.73B | 43.72B | 7.91% |
Dec 31, 2020 | 553.01B | 92.28B | 20.03% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 4,898.69B |
Celltrion | 3,662.23B |
ALTEOGEN | 151.65B |
Yuhan | 2,114.76B |
SK Biopharmaceuticals | 578.00B |
HLB Co., Ltd. | 74.64B |
Peptron | 4.30B |
PharmaResearch | 392.31B |